Summary. Detailed necropsies were performed on 26 individuals who had died of disseminated breast carcinoma, to assess the frequency of spread to the lungs, pleura and pericardium, and to determine the likely routes of spread to these sites. Tumour was present in the lung parenchyma in 67% of the lungs examined, in the visceral pleura in 75%o and the parietal pleura in 5Oo0. Although even small deposits of pleural tumour were invariably visible to naked-eye examination, lung parenchymal involvement was almost invariably microscopic, despite its frequently extensive distribution. This finding draws attention to the difficulties of clinical staging with respect to lung metastases. Tumour in lymphatics predominated over that in blood vessels in both lung and pleura and this, together with the widespread mediastinal lymphnode infiltration found, suggests that the lymphatic system forms the dominant route of spread of breast carcinoma to the thorax. The possible role of mediastinal lymphatics in the dissemination of breast cancer to bone and liver is also discussed. Our findings suggest that the fields of adjuvant irradiation after primary surgery should include the mediastinal lymphatic network.
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IT IS COMMONLY BELIEVED that the spread of breast cancer beyond the regional lymph nodes is haematogenous. However, the distinct clinical pattern of laterality of pleural effusions in breast cancer suggests a non-haematogenous mechanism of dissemination. When a pleural effusion develops for the first time in patients with unilateral breast cancer, it is usually on the same side as the primary breast lesion (Stoll & Ellis, 1953; Porter, 1965) . This pattern of spread would be better explained by a regional mechanism of dissemination, because haematogenous tumour spread should involve both sides of the thorax synchronously and with equal frequency.
Our previous necropsy experience had shown that disease within lymphatics was common at sites remote from the breast, especially in lung and pleura. We were also aware that visceral pleural disease was invariably macroscopic, whilst lung parenchymal disease was almost invariably microscopic. These observations prompted us to investigate the incidence of pulmonary and pleural metastases in breast cancer, to determine the extent of involvement of various mediastinal lymphnode groups, and to compare the frequency of intralymphatic and intravascular (blood) tumour. In this way further information on the mechanism of spread of breast cancer to the thorax might be obtained. and 4-8 blocks taken to include any macroscopically abnormal zones.
Lymph nodes were dissected from the following intrathoracic groups: (a) right and left internal mammary, (b) right and left superior mediastinal, (c) right and left pericardial, (d) right and left paratracheal, (e) right and left bronchopulmonary, and (f) posterior mediastinal (paraoesophageal). Groups (b) and (c) represent nodes from the superior and inferior portions of the anterior mediastinum respectively. Both lungs were inflated with formol saline and after 1-2 h the visceral pleural surface was examined for evidence of metastases and the lung cut into slices 1 cm thick. The lung parenchyma was similarly examined and blocks taken from each lung to include 2 from the periphery with overlying visceral pleura and 2 from the neighbourhood of the hilum to contain large bronchi and vessels. A detailed macroscopic examination was then made of the right and left parietal pleura and pericardium and 1-3 blocks taken from each to include any suspicious regions.
Histological examination was made on conventional paraffin-embedded sections stained with haematoxylin and eosin. Reticulin stains were also frequently used to facilitate the identification of small vessels.
All samples of breast tissue and lymph nodes were examined histologically. In addition to the identification of infiltrating tumour in sections of lung parenchyma, visceral pleura, parietal pleura and pericardium, evidence of intralymphatic or intravascular tumour was sought. A vessel was considered to be lymphatic if the following criteria were satisfied: (a) it was a thin-walled structure without a significant muscle coat (b) it contained no red blood cells and (c) in the lung, it was present in correct anatomical location in perivascular, peribronchial or septal regions. (56) 11 (28) 4 (10) 2 (5) Lung parenchymal metastases were detected in 35 (67%) of the 52 lungs examined but were macroscopically visible in only 4 (11%). This was partly due to the small size of the deposits and partly due to the fact that tumour was largely distributed in the perivascular, peribronchial and septal areas (the normal anatomical distribution of lymphatic vessels) where it blended with the connectivetissue elements. The lack of macroscopic detection and the relative volumes involved almost certainly led to some sampling errors, with significant underestimation of the incidence of lung parenchymal disease. Tumour was present in lymphatics in 83% (Fig. 4) and in blood vessels in 32% (Fig. 5 ) of the lungs involved. The histological findings in the lungs are summarized in Table II .
RESULTS

Bilateral
The parietal pleura of-each hemithorax was examined separately, and metastases were found in 26 (50%) of 52 cases. Several patterns of spread were seen. One of these 37 was largely postero-medial ( Fig. 6 ) with tumour extending from the vertebral column in lines above and below the ribs (Fig. 7) . This presumably represents retrograde spread along the intercostal lymphatic vessels from the posterior intercostal nodes. Spread was rarely seen fanning out in lines along the anterior parietal pleura from the internal mammary chain. In a number of cases, tumour was largely confined to the lower chest wall and diaphragm and here lymphatics penetrating the diaphragm and draining the liver seem to be implicated. Transdiaphragmatic lymphatic spread was seen histologically in 2 cases. On histological examination of the parietal pleura, tumour was present in lymphatics in 11 (42%) and in blood vessels in 1 (4%). The remainder showed infiltrating tumour only.
The pericardium contained metastatic tumour in 9 (35%) of 26 cases. Intralymphatic tumour was found in 3 (33%)
cases and intravascular tumour in no (40) 7 (20) 6 (17) 4 (11) 2 (6) 0 (0) 2 (6) cases. The remaining 6 (67%) cases showed infiltrating tumour only.
An extensive network of communications between mediastinal lymphnode groups both on one side and across the mediastinum has been demonstrated by dissection, dye-injection studies and lymphoscintigraphy (Rouviere, 1932; Sapin & Borsiak, 1974; Ege, 1978) . Although the internal mammary nodes normally drain into the bronchomediastinal trunk, lymphatic obstruction by tumour in the upper intercostal spaces may redirect the lymph flow to other lymphnode groups in the mediastinum.
The following evidence suggests that the direction of spread of breast carcinoma within pulmonary lymphatics is usually from tracheobronchial nodes centrifugally to the lung periphery rather than vice versa. Firstly in the 12 lungs with no evidence of metastatic disease in either parenchyma or visceral pleura, ipsilateral tracheobronchial nodes contained tumour in 7 (58%). Secondly, in the 35 (67%) lungs which showed evidence of intralymphatic disease in either parenchyma or visceral pleura, ipsilateral tracheobronchial nodes were found to contain tumour in 34 (97%). The lungs in the present study exhibited a characteristic pattern of spread, with macroscopic visceral pleural disease and microscopic, predominantly intralymphatic, parenchymal infiltration. Haagensen (1971) refers to this as the lymphangitic type of spread as distinct from the nodular type which exhibits macroscopically visible nodules of tumour infiltration and which we saw in only 4 lungs. Although Haagensen uses the term lymphangitic, he argues that the primary spread to the lung and pleura is haematogenous and that lymphatic permeation follows by extension from blood-borne deposits. However, the relative frequency of tumour within pulmonaryparenchymal lymphatics compared with blood vessels in the present study suggests that this does not occur with any great frequency; furthermore, the foci of infiltrating parenchymal tumour tended to be lymphatic rather than blood vascular in their anatomical distribution. The clinical laterality of pleural effusions contralateral breast suggests that contralateral mediastinal lymphatic dissemination may sometimes be from a second occult primary tumour.
The predominance of the lymphatic route in the spread of breast cancer to the thorax raises the question of its role in metastasis to other organs. Handley (1 922) described lymphatic communications between the breast and liver via the prepericardial lymph nodes on the anterior surface of the diaphragm, and standard anatomical texts describe the lymphatic drainage of the upper surface of the liver to the lowermost internal mammary nodes. The localization of bone spread to the axial skeleton also suggests a regional rather than a systemic mechanism of dissemination, but this has been explained by communications between intercostal veins and the paravertebral venous plexus (Batson, 1940) . It is usually stated that breast cancer reaches the tributaries of the intercostal veins by direct invasion, but access could also be by lymphaticovenous communications from metastatic intrathoracic lymphatics.
The importance of dissemination of breast cancer by intrathoracic lymphatics may be relevant to the fields of adjuvant irradiation after primary surgical treatment, about which there has always been controversy. The results of almost all randomized trials comparing mastectomy with mastectomy plus irradiation conclude that postoperative irradiation lowers the incidence of local recurrence but does not affect survival (Fisher et al., 1970; Hamilton et al., 1974; H0st & Breenhovd, 1975; Cancer Research Campaign, 1976) . In all these trials, variations on the "3-field" technique of irradiation have been used, in which the chest wall and axilla are irradiated by 2 tangential fields which are intended also to deliver a tumoricidal dose to the ipsilateral internal mammary nodes. The third field is a direct anterior field to the supraclavicular nodes.
In a recent discussion of the anatomical variations of the internal mammary nodes, Fletcher & Montague (1978) conclude that during irradiation by the "3-field" technique, some of these nodes are either missed completely or receive an uncertain dose. In support of this conclusion, two further trials have been reported recently of mastectomy with and without postoperative irradiation, which conclude that survival is prolonged when the fields of postoperative irradiation guarantee tumoricidal doses to the internal mammary nodes (H0st & Breenhovd, 1977; Fletcher & Montague, 1978) . Both of these trials used the "5-field" technique of irradiation, where the chest wall and axilla are treated by two tangential fields, the supraclavicular fossa by direct anterior and posterior fields, and the ipsilateral internal mammary nodes by a direct anterior field. In both trials, the irradiation source was a 60Co unit and the tumour dose to the internal mammary chain was 5000 rad.
The mediastinum deep to the internal mammary nodes would thus have been irradiated as well and, in the average-size patient, the ipsilateral paratracheal and tracheobronchial nodes would have received 3000-3500 rad. It is accepted that size is an important determinant of response to radiotherapy, and this moderate dose of irradiation may be sufficient to eliminate small lymphnode metastases deep in the mediastinum in the early stages of dissemination. If the hypothesis presented in this paper is correct, the improved survival reported by H0st & Breenhovd (1977) could be due not only to eradication of disease in the ipsilateral internal mammary nodes but also to elimination of small tumour metastases that had already disseminated to the ipsilateral paratracheal and tracheobron chial nodes.
